The theme of ISOPP 2016 is Oncology Pharmacy Practice: a Global Perspective and you can expect to get essential updates that will enhance your work as well as examples of best practice from around the world. The program will feature speakers from 14 countries. A few of the program highlights are:
- Access to Medicines: A Global Issue - Julie Torode, UICC, Geneva, Switzerland
- Novel Immunotherapy for Melanoma: Mechanisms, Outcomes, and Future Strategies - R. Donald Harvey, Winship Cancer Institute of Emory University, Atlanta, USA
- Clinical Impact and Recent Outcomes of Immunotherapy in Solid Tumours: Is it the Pathway for Cancer Cure? - Christian Caglevic, Fundación Arturo López Pérez, Santiago, Chile
- Dermatologic Toxicities: The Superficial Side of Targeted Therapies - Mario Lacouture, Memorial Sloan Kettering Cancer Center, New York, USA
- Developing to Established...How to Define Oncology Pharmacy as a Specialty - Panelists: Harbans Dhillon, Malaysia, Tara Leslie, Canada, Annemeri Livinalli, Brazil, Klaus Meier, Germany, Shaun O'Connor, Australia, Rowena Schwartz, USA
- Pediatrics/Adolescents/Young Adults Update - Jorge Morales Vallespín, Luis Calvo Mackenna Hospital, Santiago, Chile and John Wiernikowski,McMaster Children's Hospital, Hamilton, ON, Canada
- Bone Marrow Transplant Update - Pablo Ramirez, Catholic University, Santiago, Chile and Tiene Bauters, Ghent University Hospital, Ghent, Belgium
- Communicating Medical and Oncology Information to Health Care Professionals and Patients - Gustavo Espinoza, Central de preparaciones oncológicas REDSANA, Santiago, Chile and Felice Musicco, Istituti Fisioterapici Ospitalieri Regina Elena San Gallicano, Rome, Italy
- Cultural Diversity and Awareness in Oncology - Panelists: Sara Aguayo, Chile, Tiene Bauters, Belgium, Harbans Dhillon, Malaysia, Peter Gilbar, Australia, Kellie Jones Weddle, USA, Shinya Suzuki, Japan, John Wiernikowski, Canada
The program at a glance is available on the ISOPP 2016 website. Speaker and session details are added as they become available.